Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Amortization of Deferred Charges (2016 - 2019)

Historic Amortization of Deferred Charges for Veracyte (VCYT) over the last 7 years, with Q2 2019 value amounting to $75000.0.

  • Veracyte's Amortization of Deferred Charges rose 83750.0% to $75000.0 in Q2 2019 from the same period last year, while for Mar 2020 it was $75000.0, marking a year-over-year increase of 13437.5%. This contributed to the annual value of $83000.0 for FY2019, which is 15937.5% up from last year.
  • According to the latest figures from Q2 2019, Veracyte's Amortization of Deferred Charges is $75000.0, which was up 83750.0% from $8000.0 recorded in Q1 2019.
  • In the past 5 years, Veracyte's Amortization of Deferred Charges ranged from a high of $393000.0 in Q4 2017 and a low of $8000.0 during Q1 2018
  • In the last 5 years, Veracyte's Amortization of Deferred Charges had a median value of $12000.0 in 2015 and averaged $59882.4.
  • As far as peak fluctuations go, Veracyte's Amortization of Deferred Charges soared by 165454.55% in 2016, and later plummeted by 9796.44% in 2018.
  • Quarter analysis of 5 years shows Veracyte's Amortization of Deferred Charges stood at $12000.0 in 2015, then surged by 1508.33% to $193000.0 in 2016, then soared by 103.63% to $393000.0 in 2017, then tumbled by 97.96% to $8000.0 in 2018, then skyrocketed by 837.5% to $75000.0 in 2019.
  • Its last three reported values are $75000.0 in Q2 2019, $8000.0 for Q1 2019, and $8000.0 during Q4 2018.